Q
QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

24,235 signal articles · 147 in last 24h · 115,104 total before filter · latest 1h ago
147last 24h
1832last 7d
299● bullish (7d)
168● bearish (7d)
205publishers
AllMacro323Earnings881M&A104Regulatory23Product17Analyst24
✕ clear all filterssentiment: neutralSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Is Atlassian (TEAM) Hiring Ken Exner To Deepen Its Enterprise Security Push?
Simply Wall St.8d agoneutral
Is Atlassian (TEAM) Hiring Ken Exner To Deepen Its Enterprise Security Push?

Atlassian (NasdaqGS:TEAM) appoints Ken Exner as Chief Product Officer for Enterprise and Emerging products. Exner brings roughly three decades of product leadership experience from Amazon Web Services and Elastic. The role centers on expanding Atlassian's enterprise solutions and security focused offerings. The move comes as demand grows for cloud tools with strong governance, compliance, and security features. For readers watching Atlassian's leadership moves and looking for more companies...

NANO Nuclear Energy (NNE) After AFWERX Deal Has Its Undervalued Narrative Back In Focus
Simply Wall St.8d agoneutral
NANO Nuclear Energy (NNE) After AFWERX Deal Has Its Undervalued Narrative Back In Focus

NANO Nuclear Energy (NNE) stock is in focus after the company was selected by AFWERX for a SBIR Phase I contract centered on its KRONOS MMR Energy System for Air Force applications. See our latest analysis for NANO Nuclear Energy. The AFWERX contract and upcoming third quarter 2026 business update come after a mixed period for NANO Nuclear Energy, with the share price down 36.2% year to date but up over the past week, while the 1 year total shareholder return has declined 52.3%. If you want...

Moderna (MRNA) Starts Phase 1 Canada Trial For Bundibugyo Ebola mRNA Vaccine
Simply Wall St.8d agoneutral
Moderna (MRNA) Starts Phase 1 Canada Trial For Bundibugyo Ebola mRNA Vaccine

Moderna (NasdaqGS:MRNA) has initiated a Phase 1 clinical trial in Canada for its investigational mRNA vaccine targeting Bundibugyo ebolavirus. The program addresses a strain of Ebola that currently has no approved vaccine and is positioned as part of Moderna's broader infectious disease portfolio. The trial involves collaboration with CEPI and Canadian public health authorities, with a stated focus on access for low and middle income countries. This kind of targeted vaccine work highlights...

Cloudflare second quarter results boosted by strong AI demand
Proactive8d agoneutral
Cloudflare second quarter results boosted by strong AI demand

Cloudflare (NYSE:NET) shares were set to open sharply higher on Friday after the cloud connectivity company reported second quarter results that topped analyst expectations and issued stronger-than-expected guidance for the current quarter. Shares of Cloudflare were indicated to open about...

The future of the NextEra-Dominion megadeal
Axios8d agoneutral
The future of the NextEra-Dominion megadeal

The profile of the proposed $67 billion merger between NextEra and Dominion just got even higher — and the path toward creating a new power giant just got even trickier.

Traders Scale Back Bets on Rate Hike
The Wall Street Journal8d agoneutral
Traders Scale Back Bets on Rate Hike

Friday’s weaker-than-expected jobs report has flipped the market-based odds of whether the Federal Reserve raises interest rate in September. Interest-rate futures now show a 56% chance that the Fed stays on hold at its next meeting and a 44% chance of a rate hike, according to CME Group data.

Can MU Stock Compound Its Way Higher?
Trefis8d agoneutral
Can MU Stock Compound Its Way Higher?

A company known for cyclicality is locking in its future. Micron has signed strategic agreements with customers that include take-or-pay commitments. These 14 contracts alone represent approximately $100 billion in cumulative revenue at a minimum price. This move attempts to build a floor under a historically volatile business.

Benzinga8d agoneutral
Elon Musk Says SpaceX Will Consume Three Times More Terafab AI Compute Than Tesla

Tesla Inc. (NASDAQ:TSLA) and Space Exploration Technologies Corp. (NASDAQ:SPCX) CEO Elon Musk says that the new Terafab semiconductor manufacturing facility in Grimes County, Texas, will serve both the Optimus robot and SpaceX’s “AI spacecraft”. Elon Musk’s Approximate Guesses On Thursday, the Tesla Owners Silicon Valley handle on X shared a promotional video of the Terafab facility, saying that the site will “produce over 1 terawatt of AI compute capacity per year” and that it would be a crucia

Cloud AI Update - Fortude Revolutionizes ERP with AI-Driven Delivery Model
Simply Wall St.8d agoneutral
Cloud AI Update - Fortude Revolutionizes ERP with AI-Driven Delivery Model

Fortude has launched an innovative AI-driven delivery model for ERP implementations using Infor CloudSuite. This model integrates industry accelerators with AI agents and human oversight to streamline and expedite the ERP implementation process, reducing costs and enhancing efficiency. By utilizing AI to automate repetitive tasks and organized project knowledge, Fortude aims to provide faster and more affordable ERP solutions, thereby allowing businesses to concentrate on data, automation,...

Take-Two Logs Higher Sales but Loss Widens
The Wall Street Journal8d agoneutral
Take-Two Logs Higher Sales but Loss Widens

The video-game company recorded higher sales in its fiscal first quarter but losses widened due to discontinued development of a title in its pipeline.